Lymph Node Yield in Colon Cancer Resection Specimens
Overview
In this study, we aimed to develop a predictive model of lymph node yield in a series of colon cancer resection specimens with detailed anatomic and surgical technique data.
Full Title of Study: “Macroscopic Evaluation of Colon Cancer Resection Specimens to Predict Metastatic Lymph Node Yield”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: July 1, 2020
Detailed Description
Lymph node yield in colon resection specimens has been associated with the accuracy of staging and cancer outcomes. It has been proposed that the more central the mesenteric vascular ligation, the greater the nodal yield. However, the optimal number of harvested nodes is still a matter of debate. We prospectively evaluated the relation between specimen properties such as lenght, area, tumor location and pedicle length to the number of harvested nodes and rate of node positivity.
Interventions
- Procedure: Calculation of metric variables on the colectomy specimens.
- Calculation of metric variables on the colectomy specimens including Lengths as mm Proximal colon, Ileum in cases with right hemicolectomy only, Proximal border, Tumor, Distal border, Total specimen, Vascular pedicle, the longitudinal distance between the nearest bowel wall and the end of ligated major vascular pedicle depending on the tumor’s localization, 2. Colonic mesenteric area as mm2.
Clinical Trial Outcome Measures
Primary Measures
- Lymph Node Yield in Colon Cancer Resection Specimens
- Time Frame: September 2019- November 2020
- Count of lymph node
- Lymph Node Yield in Colon Cancer Resection Specimens
- Time Frame: September 2019-November 2020
- Involvement of lymph node
Participating in This Clinical Trial
Inclusion Criteria
The surgical patients with a histologic diagnosis of colonic neoplasm, Colectomy of any type, including the right hemicolectomy, the left hemicolectomy, the sigmoid resection, segmental colon resection Exclusion Criteria:
- rectal or rectosigmoid cancer colectomy beyond the inclusion criteria for colectomies patients younger than 18 previous colon resection emergency colon resection familial adenomatous polyposis or ulcerative colitis
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Bagcilar Training and Research Hospital
- Provider of Information About this Clinical Study
- Principal Investigator: Nadir Adnan Hacım, Dr. – Bagcilar Training and Research Hospital
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.